Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.

Volume 2 (2005), Issue 6 (June)

1. The safety of rofecoxib.
   Expert Opin Drug Saf, 4(3): 491-9. [Abstract] [Full-text]
2. The problem of the atherothrombotic potential of nonsteroidal anti-inflammatory drugs.
   Ann Rheum Dis. [Abstract] [Full-text]
3. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study.
   BMJ, 330(7504): 1370. [Abstract] [Full-text]
4. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
   BMJ, 330(7504): 1366. [Abstract] [Full-text]
5. Effect of selective cyclooxygenase-2 inhibitors on heart rate in healthy young men.
   Am J Cardiol, 95(12): 1531-2. [Abstract] [Full-text]
6. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital.
   Br J Clin Pharmacol, 59(6): 718-23. [Abstract] [Full-text]
7. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
   Neuropsychopharmacology, 30(6): 1204-15. [Abstract] [Full-text]
8. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.
   Cancer Res, 65(12): 5038-44. [Abstract] [Full-text]
9. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
   J Pharmacol Exp Ther, 314(1): 302-9. [Abstract] [Full-text]
10. Cancer prevention: a new era beyond cyclooxygenase-2.
    J Pharmacol Exp Ther, 314(1): 1-8. [Abstract] [Full-text]
11. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs.
    Clin Exp Allergy, 35(6): 713-6. [Abstract] [Full-text]
12. Perioperative rofecoxib plus local anesthetic field block diminishes pain and recovery time after outpatient inguinal hernia repair.
    Anesth Analg, 101(1): 83-9, table of contents. [Abstract] [Full-text]
13. Relative thromboembolic risks associated with COX-2 inhibitors.
    Ann Pharmacother, 39(7): 1249-59. [Abstract] [Full-text]
14. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Rheumatology (Oxford), 44(7): 921-4. [Abstract] [Full-text]

© 2004-2008 Vioxx Research Today. All Rights Reserved.